Global CAR T-Cell Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

SKU ID : GIR- 13723560

Publishing Date : 26-Jul-2019

No. of pages : 136


  • CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.

    Scope of the Report:
    The global CAR T-Cell Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CAR T-Cell Immunotherapy.
    Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
    This report studies the CAR T-Cell Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CAR T-Cell Immunotherapy market by product type and applications/end industries.

    Market Segment by Companies, this report covers
    Kite Pharma
    Oxford BioMedica
    Mustang Bio
    CARsgen Therapeutics
    Minerva Biotechnologies
    Ziopharm Oncology
    Aurora Biopharma
    Creative Biolabs

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Combination Therapy

    Market Segment by Applications, can be divided into
    Hematologic Malignancies
    Solid Malignancies

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports